by Stefan Ravello | Sep 13, 2024 | Oncology, Pulmonology
Immunotherapy, which has demonstrated benefits in advanced and metastatic settings, is moving into early non-small cell lung cancer treatment, expanding options for patients with resected or resectable early-stage non-small cell lung cancer. This rapid evolution of...
by Stefan Ravello | Jul 25, 2024 | Obesity Management, Weight Management, Wellness
In the United States, obesity and overweight are an epidemic and a major health concern worldwide. Excess adipose tissue can lead to diabetes, hypertension, cardiovascular disease, certain cancers, poor mental health, and musculoskeletal disorders, resulting in...
by Stefan Ravello | Jul 25, 2024 | Hematology-Oncology
Chronic lymphocytic leukemia (CLL) is the most common form of leukemia in Western countries, with an age-adjusted incidence of 4.6 per 100,000 individuals per year. As small lymphocytic lymphoma (SLL) refers to the same malignant process with primary nodal involvement...
by Stefan Ravello | Jul 25, 2024 | Neurology
The goal of this initiative is to improve the care of patients with Duchenne muscular dystrophy (DMD). DMD is the most common childhood form of muscular dystrophy and characteristic manifestations are progressive muscle weakness, cardiorespiratory impairment, and...
by Stefan Ravello | Jul 25, 2024 | Rheumatology
Immune-mediated inflammatory diseases, such as rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis, can prove challenging to address in real-world settings. Although biologics directed against TNF-α can rapidly and sustainably induce clinical...
